The share of revenue from antiretroviral formulations by Aurobindo Pharma Limited for fiscal year 2019 was five percent. The revenue generated by the company from ARV formulations was over 9.5 billion Indian rupees during financial year 2019.
Share of revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2019
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Aurobindo Pharma's revenue from ARV formulations FY 2013-2020
- Aurobindo Pharma's revenue from growth market formulations FY 2013-2020
- Aurobindo Pharma's expenditure on R&D FY 2017-2020, by type
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2020
- Aurobindo Pharma's EBITDA FY 2013-2020
- Aurobindo Pharma's revenue share 2020 by market
- Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2020
- Aurobindo Pharma's net debt to equity ratio FY 2013-2020
- Aurobindo Pharma's EBITDA margin FY 2013-2020
- Aurobindo Pharma's ANDA filings 2019 by therapy
- Dr. Reddy's Laboratories' EBITDA FY 2014-2020
- Dr. Reddy's Laboratories' net worth FY 2014-2020
- Dr. Reddy's Laboratories' return on capital employed FY 2013-2020
- Dr. Reddy's Laboratories' revenue FY 2017-2020 by product segment
- Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2020
- Dr. Reddy's Laboratories' revenue FY 2014-2020
Aurobindo Pharma. (August 2, 2019). Share of revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2019 [Graph]. In Statista. Retrieved March 09, 2021, from https://www.statista.com/statistics/996269/india-aurobindo-pharma-arv-formulations-revenue-share/
Aurobindo Pharma. "Share of revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2019 ." Chart. August 2, 2019. Statista. Accessed March 09, 2021. https://www.statista.com/statistics/996269/india-aurobindo-pharma-arv-formulations-revenue-share/
Aurobindo Pharma. (2019). Share of revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2019 . Statista. Statista Inc.. Accessed: March 09, 2021. https://www.statista.com/statistics/996269/india-aurobindo-pharma-arv-formulations-revenue-share/
Aurobindo Pharma. "Share of Revenue from Antiretroviral Drug Formulations by Aurobindo Pharma Limited from Financial Year 2013 to 2019 ." Statista, Statista Inc., 2 Aug 2019, https://www.statista.com/statistics/996269/india-aurobindo-pharma-arv-formulations-revenue-share/
Aurobindo Pharma, Share of revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2019 Statista, https://www.statista.com/statistics/996269/india-aurobindo-pharma-arv-formulations-revenue-share/ (last visited March 09, 2021)